By Leigh Dayton, 2 September 2019
Cartherics has been invited to present at the prestigious Cell & Gene Meeting on the Mesa https://www.meetingonthemesa.com/ in Carlsbad, California in October. The meeting is the sector’s leading annual conference, bringing senior industry executives together with the scientific community to advance research into cell-based therapies.
The meeting covers a variety of topics, from clinical trial design and alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, partnering and networking opportunities, and roughly 80 presentations by leading publicly traded and privately held companies.
“I’m pleased we’ve been selected to present at such an important meeting,” said Cartherics CEO and Executive Director, Alan Trounson. “There’s only one other Australian company attending,” he added, noting that it is an important opportunity to present the company’s work to a discerning and critical audience.
This year’s event is expected to attract more than 1,200 attendees, including senior executives from leading cell therapy, gene therapy, and tissue engineering companies worldwide, large pharma and biotech, institutional investors, and academic research institutions, along patient foundations and disease philanthropies.
“We hope that we may be able to create some partnering relationships as a result of the meeting,” Trounson said.
Cartherics Chief Scientific Officer, Richard Boyd, agrees. He will present details to delegates of Cartherics’ pre-clinical in vitro and animal model research, cell manufacture for clinical trials, and corporate game plan.
“To do so in such a prestigious forum is a great advance for Cartherics,” Boyd said.
He added: “This conference has now assumed the mantle of being one of the most important of the sector, because it is clear that the progression from laboratory research to clinical translation is multi-faceted – a key enabling element being strategic alliances with synergistic partners”.
The annual event is organised by the Alliance for Regenerative Medicine, https://alliancerm.org/, an international organisation focused on the issues facing regenerative medicine and advanced therapies.
Leigh Dayton is Cartherics’ Communications Advisor.